Immunovaccine Inc. (TSX-V: IMV), announced today that the US Food and Drug Administration (FDA) reviewed and cleared its Investigational New Drug (IND) application for a Phase I/II clinical study with DPX-Survivac, a therapeutic cancer vaccine. DPX-Survivac will be tested in patients with ovarian cancer.
Early stage technology companies in Cape Breton will soon have increased access to the business support they need to be successful as Innovacorp establishes an incubation facility in the area.
Venture Solutions Inc. and Innovacorp are collaborating to deliver products and services to high potential knowledge-based companies based at a business incubation facility in Sydney.
Regional co-operation in Atlantic Canada took another step forward today, June 5, as New Brunswick joined Nova Scotia in a regional venture capital fund to support emerging companies in the region.
New Brunswick will contribute $15 million to fund, created by Nova Scotia and announced in April. Companies involved in clean technology, life sciences, information technology and other high-growth sectors will be able to access the fund.
Ocean Nutrition Canada Limited (ONC), the world’s largest Omega-3 EPA/DHA solutions provider and supplier of MEG-3® brand Omega-3 EPA/DHA ingredients, has reached another milestone with over one hundred billion servings consumed globally.
SimplyCast.com, a leader in multi-channel marketing Platform-as-a-Service (PaaS) solution for organizations worldwide, today announced it has elected J. William (Bill) Ritchie as the chairman of its board of directors.
Nova Scotian clean technology companies will have better access to capital through a new, $24-million provincial fund.
Premier Darrell Dexter announced today, April 13, that the province, through Innovacorp, is launching the fund as part of jobsHere, Nova Scotia's plan to grow the economy.
Seaforth Energy Inc., a leading wind turbine manufacturer and renewable energy integrator, will receive $1.9 million from the Atlantic Canada Opportunities Agency (ACOA) under the Atlantic Innovation Fund (AIF) to develop new wind turbines.
The funding will be used towards Seaforth Energy’s $2.9 million R&D project already underway to extend its proven AOC turbine product line.
Immunovaccine Inc. (TSX-V: IMV), a clinical stage vaccine developer, will receive $2.9 million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF).
This non-dilutive funding will enable Immunovaccine to develop new diagnostics to identify specific subsets of cancer patient populations that would benefit most from receiving DepoVax™-based vaccine therapies. This funding will also help the company develop additional methods for measuring vaccine activity, information that will help the company design future Phase II clinical trials.
Early stage technology companies in the province are getting improved access to scientific and technology expertise thanks to Innovacorp's new advisory council.
"I'm delighted to have a group of this calibre as a resource for us and our clients," said Clifford Gross, president and CEO of Innovacorp. "Their experience, knowledge of science and industry, and contacts in the global community will be invaluable.
"The council will also be a great platform for assessing emerging science and technology issues important to Nova Scotia's economic future."
Equals6, the Halifax based student career development network, announced the launch of its Top-Talent Scholarship program today, Feb. 28.